Back to BIO Stock Lookup

BIO – Press Releases

Apr 16, 2014 12:32 PM Bio-Rad to Report First-Quarter 2014 Financial Results Tuesday, May 6, 2014
Apr 16, 2014 01:00 AM BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company
Apr 14, 2014 12:11 PM BioAlliance Pharma Announces a New Positive DSMB Recommendation to Continue Its Phase III Clinical Trial with Livatag® in Primary Liver Cancer
Apr 11, 2014 08:41 AM Bio-Rad Acquires GnuBIO, Developer of Droplet-Based DNA Sequencing Technology
Apr 10, 2014 08:00 PM Bio-Rad Acquires GnuBIO and DNA Sequencing Technology
Apr 2, 2014 02:00 AM BioAlliance Pharma signs a new licensing agreement with Daewoong Pharmaceutical Co., Ltd. for Sitavig®’s commercialization in South Korea
Apr 1, 2014 01:00 PM BioAlliance Pharma provides an update on its partnerships for Loramyc®/Oravig®
Mar 31, 2014 12:06 PM BioAlliance Pharma Collaborates with Penn Pharma on the Industrial Development of Validive®
Mar 19, 2014 02:00 AM BioAlliance Pharma: Sitavig® Licensing Strategy
Feb 27, 2014 04:15 PM Bio-Rad Reports Fourth-Quarter and Full-Year 2013 Financial Results
Feb 27, 2014 12:00 PM BioAlliance Pharma Provides Updates on Its Major Achievements and Reports 2013 Consolidated Financial Results
Feb 18, 2014 12:00 PM BioAlliance Pharma SA: Strengthening and extension of the industrial protection of Livatag® until 2031
Feb 4, 2014 12:00 PM BioAlliance Pharma’s Partner, Sosei, Announces a Partnership With FUJIFILM Pharma for Commercialization Rights for Loramyc® in Japan
Jan 27, 2014 07:43 PM Bio-Rad to Report Fourth-Quarter and Full-Year 2013 Financial Results Thursday, February 27, 2014
Jan 23, 2014 01:00 AM BioAlliance Pharma : FDA Grants Validive® (clonidine Lauriad®) with a Fast Track Designation for the Prevention and Treatment of Oral Mucositis Induced by Anticancer Treatments

Back to BIO Stock Lookup